Logo image of SOLB.BR

SOLVAY SA (SOLB.BR) Stock Fundamental Analysis

Europe - Euronext Brussels - EBR:SOLB - BE0003470755 - Common Stock

25.3 EUR
+0.5 (+2.02%)
Last: 1/21/2026, 3:46:12 PM
Fundamental Rating

5

SOLB gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 69 industry peers in the Chemicals industry. There are concerns on the financial health of SOLB while its profitability can be described as average. SOLB is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year SOLB was profitable.
  • In the past year SOLB had a positive cash flow from operations.
  • Of the past 5 years SOLB 4 years were profitable.
  • SOLB had a positive operating cash flow in each of the past 5 years.
SOLB.BR Yearly Net Income VS EBIT VS OCF VS FCFSOLB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

  • SOLB's Return On Assets of 2.43% is in line compared to the rest of the industry. SOLB outperforms 59.42% of its industry peers.
  • SOLB's Return On Equity of 12.80% is fine compared to the rest of the industry. SOLB outperforms 72.46% of its industry peers.
  • SOLB has a better Return On Invested Capital (8.40%) than 72.46% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for SOLB is above the industry average of 6.70%.
Industry RankSector Rank
ROA 2.43%
ROE 12.8%
ROIC 8.4%
ROA(3y)13.55%
ROA(5y)7.71%
ROE(3y)64.09%
ROE(5y)37.45%
ROIC(3y)11.19%
ROIC(5y)8.96%
SOLB.BR Yearly ROA, ROE, ROICSOLB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.14%, SOLB is in line with its industry, outperforming 57.97% of the companies in the same industry.
  • In the last couple of years the Profit Margin of SOLB has grown nicely.
  • The Operating Margin of SOLB (10.89%) is better than 71.01% of its industry peers.
  • In the last couple of years the Operating Margin of SOLB has grown nicely.
  • The Gross Margin of SOLB (21.24%) is worse than 69.57% of its industry peers.
  • SOLB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.89%
PM (TTM) 3.14%
GM 21.24%
OM growth 3Y5%
OM growth 5Y4.03%
PM growth 3Y-17.12%
PM growth 5Y176.86%
GM growth 3Y-4.43%
GM growth 5Y-3.41%
SOLB.BR Yearly Profit, Operating, Gross MarginsSOLB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SOLB is creating value.
  • Compared to 1 year ago, SOLB has less shares outstanding
  • SOLB has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, SOLB has a worse debt to assets ratio.
SOLB.BR Yearly Shares OutstandingSOLB.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SOLB.BR Yearly Total Debt VS Total AssetsSOLB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

  • Based on the Altman-Z score of 1.66, we must say that SOLB is in the distress zone and has some risk of bankruptcy.
  • SOLB has a worse Altman-Z score (1.66) than 73.91% of its industry peers.
  • The Debt to FCF ratio of SOLB is 7.54, which is on the high side as it means it would take SOLB, 7.54 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 7.54, SOLB is doing good in the industry, outperforming 60.87% of the companies in the same industry.
  • A Debt/Equity ratio of 1.70 is on the high side and indicates that SOLB has dependencies on debt financing.
  • SOLB's Debt to Equity ratio of 1.70 is on the low side compared to the rest of the industry. SOLB is outperformed by 89.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF 7.54
Altman-Z 1.66
ROIC/WACC1.36
WACC6.18%
SOLB.BR Yearly LT Debt VS Equity VS FCFSOLB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

  • SOLB has a Current Ratio of 1.41. This is a normal value and indicates that SOLB is financially healthy and should not expect problems in meeting its short term obligations.
  • SOLB has a worse Current ratio (1.41) than 62.32% of its industry peers.
  • A Quick Ratio of 1.04 indicates that SOLB should not have too much problems paying its short term obligations.
  • SOLB has a Quick ratio (1.04) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.04
SOLB.BR Yearly Current Assets VS Current LiabilitesSOLB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2

3. Growth

3.1 Past

  • SOLB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -93.13%.
  • Measured over the past years, SOLB shows a very strong growth in Earnings Per Share. The EPS has been growing by 153.72% on average per year.
  • Looking at the last year, SOLB shows a very negative growth in Revenue. The Revenue has decreased by -50.46% in the last year.
  • SOLB shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -14.50% yearly.
EPS 1Y (TTM)-93.13%
EPS 3Y-37%
EPS 5Y153.72%
EPS Q2Q%-16.16%
Revenue 1Y (TTM)-50.46%
Revenue growth 3Y-23.45%
Revenue growth 5Y-14.5%
Sales Q2Q%-9.69%

3.2 Future

  • The Earnings Per Share is expected to decrease by -2.59% on average over the next years.
  • The Revenue is expected to decrease by -0.08% on average over the next years.
EPS Next Y-20.31%
EPS Next 2Y-13.41%
EPS Next 3Y-4.95%
EPS Next 5Y-2.59%
Revenue Next Year-4.56%
Revenue Next 2Y-2.21%
Revenue Next 3Y-0.48%
Revenue Next 5Y-0.08%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SOLB.BR Yearly Revenue VS EstimatesSOLB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B
SOLB.BR Yearly EPS VS EstimatesSOLB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

  • SOLB is valuated cheaply with a Price/Earnings ratio of 6.93.
  • SOLB's Price/Earnings ratio is rather cheap when compared to the industry. SOLB is cheaper than 97.10% of the companies in the same industry.
  • SOLB's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.94.
  • Based on the Price/Forward Earnings ratio of 8.25, the valuation of SOLB can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, SOLB is valued cheaper than 98.55% of the companies in the same industry.
  • SOLB is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.93
Fwd PE 8.25
SOLB.BR Price Earnings VS Forward Price EarningsSOLB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SOLB is valued cheaper than 91.30% of the companies in the same industry.
  • SOLB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. SOLB is cheaper than 97.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.14
EV/EBITDA 5.39
SOLB.BR Per share dataSOLB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • SOLB has a very decent profitability rating, which may justify a higher PE ratio.
  • SOLB's earnings are expected to decrease with -4.95% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.05
EPS Next 2Y-13.41%
EPS Next 3Y-4.95%

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 6.18%, SOLB is a good candidate for dividend investing.
  • SOLB's Dividend Yield is rather good when compared to the industry average which is at 2.33. SOLB pays more dividend than 94.20% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.83, SOLB pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.18%

5.2 History

  • The dividend of SOLB decreases each year by -9.94%.
Dividend Growth(5Y)-9.94%
Div Incr Years3
Div Non Decr Years4
SOLB.BR Yearly Dividends per shareSOLB.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • SOLB pays out 164.94% of its income as dividend. This is not a sustainable payout ratio.
  • SOLB's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP164.94%
EPS Next 2Y-13.41%
EPS Next 3Y-4.95%
SOLB.BR Yearly Income VS Free CF VS DividendSOLB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B
SOLB.BR Dividend Payout.SOLB.BR Dividend Payout, showing the Payout Ratio.SOLB.BR Dividend Payout.PayoutRetained Earnings

SOLVAY SA

EBR:SOLB (1/21/2026, 3:46:12 PM)

25.3

+0.5 (+2.02%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06
Earnings (Next)02-24
Inst Owners29.1%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.68B
Revenue(TTM)4.91B
Net Income(TTM)154.00M
Analysts53.6
Price Target28.08 (10.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.18%
Yearly Dividend2.44
Dividend Growth(5Y)-9.94%
DP164.94%
Div Incr Years3
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.12%
Min EPS beat(2)9%
Max EPS beat(2)31.25%
EPS beat(4)3
Avg EPS beat(4)12.33%
Min EPS beat(4)-1.96%
Max EPS beat(4)31.25%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.52%
Min Revenue beat(2)-2.48%
Max Revenue beat(2)-0.57%
Revenue beat(4)0
Avg Revenue beat(4)-2.19%
Min Revenue beat(4)-4.75%
Max Revenue beat(4)-0.57%
Revenue beat(8)2
Avg Revenue beat(8)-0.66%
Revenue beat(12)5
Avg Revenue beat(12)2.07%
Revenue beat(16)9
Avg Revenue beat(16)7.99%
PT rev (1m)-0.48%
PT rev (3m)-6.67%
EPS NQ rev (1m)4.55%
EPS NQ rev (3m)-12.88%
EPS NY rev (1m)-0.32%
EPS NY rev (3m)-2.08%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)1.62%
Revenue NY rev (1m)1.41%
Revenue NY rev (3m)0.75%
Valuation
Industry RankSector Rank
PE 6.93
Fwd PE 8.25
P/S 0.55
P/FCF 9.14
P/OCF 4.49
P/B 2.23
P/tB 11.85
EV/EBITDA 5.39
EPS(TTM)3.65
EY14.43%
EPS(NY)3.07
Fwd EY12.12%
FCF(TTM)2.77
FCFY10.94%
OCF(TTM)5.63
OCFY22.25%
SpS46.33
BVpS11.36
TBVpS2.13
PEG (NY)N/A
PEG (5Y)0.05
Graham Number30.55
Profitability
Industry RankSector Rank
ROA 2.43%
ROE 12.8%
ROCE 11.2%
ROIC 8.4%
ROICexc 8.4%
ROICexgc 10.56%
OM 10.89%
PM (TTM) 3.14%
GM 21.24%
FCFM 5.97%
ROA(3y)13.55%
ROA(5y)7.71%
ROE(3y)64.09%
ROE(5y)37.45%
ROIC(3y)11.19%
ROIC(5y)8.96%
ROICexc(3y)12.43%
ROICexc(5y)9.87%
ROICexgc(3y)17.2%
ROICexgc(5y)14.4%
ROCE(3y)14.91%
ROCE(5y)11.94%
ROICexgc growth 3Y8.77%
ROICexgc growth 5Y9.63%
ROICexc growth 3Y18.23%
ROICexc growth 5Y16.44%
OM growth 3Y5%
OM growth 5Y4.03%
PM growth 3Y-17.12%
PM growth 5Y176.86%
GM growth 3Y-4.43%
GM growth 5Y-3.41%
F-Score5
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF 7.54
Debt/EBITDA 2.28
Cap/Depr 83.47%
Cap/Sales 6.18%
Interest Coverage 7.63
Cash Conversion 66.44%
Profit Quality 190.26%
Current Ratio 1.41
Quick Ratio 1.04
Altman-Z 1.66
F-Score5
WACC6.18%
ROIC/WACC1.36
Cap/Depr(3y)94.75%
Cap/Depr(5y)76.26%
Cap/Sales(3y)9.62%
Cap/Sales(5y)7.99%
Profit Quality(3y)83.5%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-93.13%
EPS 3Y-37%
EPS 5Y153.72%
EPS Q2Q%-16.16%
EPS Next Y-20.31%
EPS Next 2Y-13.41%
EPS Next 3Y-4.95%
EPS Next 5Y-2.59%
Revenue 1Y (TTM)-50.46%
Revenue growth 3Y-23.45%
Revenue growth 5Y-14.5%
Sales Q2Q%-9.69%
Revenue Next Year-4.56%
Revenue Next 2Y-2.21%
Revenue Next 3Y-0.48%
Revenue Next 5Y-0.08%
EBIT growth 1Y-59.02%
EBIT growth 3Y-19.61%
EBIT growth 5Y-11.06%
EBIT Next Year21.58%
EBIT Next 3Y9.38%
EBIT Next 5Y5.86%
FCF growth 1Y-75.88%
FCF growth 3Y-27.42%
FCF growth 5Y-19.2%
OCF growth 1Y-74.87%
OCF growth 3Y-25.69%
OCF growth 5Y-19.46%

SOLVAY SA / SOLB.BR FAQ

What is the ChartMill fundamental rating of SOLVAY SA (SOLB.BR) stock?

ChartMill assigns a fundamental rating of 5 / 10 to SOLB.BR.


What is the valuation status of SOLVAY SA (SOLB.BR) stock?

ChartMill assigns a valuation rating of 8 / 10 to SOLVAY SA (SOLB.BR). This can be considered as Undervalued.


What is the profitability of SOLB stock?

SOLVAY SA (SOLB.BR) has a profitability rating of 6 / 10.


What is the valuation of SOLVAY SA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SOLVAY SA (SOLB.BR) is 6.93 and the Price/Book (PB) ratio is 2.23.


Can you provide the financial health for SOLB stock?

The financial health rating of SOLVAY SA (SOLB.BR) is 3 / 10.